Skip to main content

Table 3 Factors associated with insulin resistance, models with general obesity or abdominal obesity

From: Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon

Variables

Modalities

IR + (n = 214)

IR - (n = 238)

aAdjusted odds ratio (95% CI)

p

bAdjusted odds ratio (95% CI)

p

Gender

- Male

36 (16.8)

55 (23.1)

1.06 (0.49–2.89)

0.888

1.21 (0.52–2.83)

0.660

- Female

178 (83.2)

183 (76.9)

1

1

Age

- ≥ 46

84 (39.3)

90 (37.8)

1,31 (0.45–3.79)

0.618

1.45 (0.51–4.16)

0.485

- < 46

130 (60.7)

148 (62.2)

1

 

1st line with NNRTIs

- yes

211 (98.6)

162 (68.1)

0.91 (0.32–2.56)

0.854

0.87 (0.31–2.43)

0.790

 

- no

13 (1.4)

14 (31.9)

1

 

1

 

2nd line with PIs

- yes

10 (4.7)

17 (7.1)

0.94 (0.17–5.37)

0.944

0.93 (0.17–5.56)

0.935

- no

179 (95.3)

194 (92.9)

1

1

 

Metabolic syndrome

- yes

35 (16.4)

18 (7.6)

1.10 (0.43–2.81)

0.845

0.98 (0.36–2.70)

0.968

- no

179 (83.6)

220 (92.4)

1

1

Hypertension

- yes

38 (17.8)

22 (9.2)

1.91 (0.89–4.08)

0.096

1.87 (0.87–4.01)

0.109

- no

176 (82.2)

216 (90.8)

1

1

Diabetes

- yes

7 (3.3)

2 (0.8)

7.34 (0.86–62.74)

0.069

8.36 (0.97–72.10)

0.053

- no

207 (96.7)

236 (99.2)

1

1

General obesity

- yes

62 (29.0)

26 (10.9)

2.28 (1.10–4.72)

0.027

  

- no

152 (71.0)

212 (89.1)

1

 

Abdominal obesity

- yes

112 (52.3)

83 (34.9)

  

2.11 (0.95–4.69)

0.068

- no

102 (47.7)

155 (65.1)

 

1

  1. aAdjusted for: gender, age, PIs, NNRTIs, obesity, diabetes, hypertension, metabolic syndrome and general obesity.
  2. bAdjusted for: gender, age, PIs, NNRTIs, obesity, diabetes, hypertension, metabolic syndrome and abdominal obesity. Factors are presented as count (percentage)
  3. NNRTIs non-nucleoside reverse transcriptase inhibitors, PIs protease inhibitors, IR + participants with insulin resistance, IR- participants without insulin resistance